UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000059575 |
|---|---|
| Receipt number | R000068058 |
| Scientific Title | Development and Validation of a Personality-Type Questionnaire Associated with Smoking and Smoking-Cessation Behaviors: Questionnaire of User's Individual Traits |
| Date of disclosure of the study information | 2025/11/24 |
| Last modified on | 2025/11/17 18:02:11 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Development and Validation of a Personality-Type Questionnaire Associated with Smoking and Smoking-Cessation Behaviors: Questionnaire of User's Individual Traits
Acronym
QUIT study
Scientific Title
Development and Validation of a Personality-Type Questionnaire Associated with Smoking and Smoking-Cessation Behaviors: Questionnaire of User's Individual Traits
Scientific Title:Acronym
QUIT study
Region
| Japan |
Condition
Condition
smoker
Classification by specialty
| Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
The purpose of this study is to develop a questionnaire to identify personality types specifically related to smoking and smoking cessation behaviors.
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
We developed a questionnaire to identify personality types specifically related to smoking and smoking cessation behaviors,called the Questionnaire of User's Individual Traits (QUIT).
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 70 | years-old | > |
Gender
Male and Female
Key inclusion criteria
Age 20 years or older and under 70 years
Smoker
Key exclusion criteria
Individuals who cannot use the web
Cases where the principal investigator or co-investigators determine that participation in this study is inappropriate
Target sample size
300
Research contact person
Name of lead principal investigator
| 1st name | Mitsuko |
| Middle name | |
| Last name | Onda |
Organization
Osaka Medical and Pharmaceutical UniversityFaculty of Pharmacy
Division name
Department of Social and Administrative Pharmacy
Zip code
569-1094
Address
4-20-1, Nasahara, Takatsuki, Osaka
TEL
072-690-1000
mitsuko.onda@ompu.ac.jp
Public contact
Name of contact person
| 1st name | Naoki |
| Middle name | |
| Last name | Sakane |
Organization
National Hospital Organization Kyoto Medical Center
Division name
Clinical Research Institute
Zip code
612-8555
Address
1-1 Mukaihata-cho, Fukakusa, Fushimi-ku, Kyoto
TEL
0756419161
Homepage URL
404-j-doit1@mail.hosp.go.jp
Sponsor or person
Institute
National Hospital Organization Kyoto Medical Center
Institute
Department
Personal name
Funding Source
Organization
Japan Society for the Promotion of Science
Organization
Division
Category of Funding Organization
Japanese Governmental office
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
National Hospital Organization Kyoto Medical Center
Address
1-1 Mukaihata-cho, Fukakusa, Fushimi-ku, Kyoto, Japan.
Tel
0756419161
404-j-doit1@mail.hosp.go.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2025 | Year | 11 | Month | 24 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2025 | Year | 10 | Month | 31 | Day |
Date of IRB
| 2025 | Year | 11 | Month | 17 | Day |
Anticipated trial start date
| 2025 | Year | 11 | Month | 18 | Day |
Last follow-up date
| 2028 | Year | 11 | Month | 30 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
investigative study
Management information
Registered date
| 2025 | Year | 10 | Month | 29 | Day |
Last modified on
| 2025 | Year | 11 | Month | 17 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068058
